11/14/2024
6:00 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/05/2024
6:15 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2024
3:30 PM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024
3:40 PM | AC Immune (Subject)
Pfeifer Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/17/2024
6:02 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024
8:04 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/06/2024
3:50 PM | AC Immune (Filer)
| Form 424B5 | |
|
08/06/2024
6:15 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2024
11:15 PM | AC Immune (Filer)
| Form EFFECT | |
07/31/2024
7:35 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024
3:53 PM | AC Immune (Filer)
| Form F-3/A | |
07/25/2024
7:00 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/20/2024
3:35 PM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024
7:00 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024
1:23 PM | AC Immune (Subject)
AFFIRIS AG in Liqu (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
5:00 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024
5:16 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
3:43 PM | AC Immune (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
03/14/2024
6:44 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024
6:30 AM | AC Immune (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/09/2024
3:30 PM | AC Immune (Subject)
AFFIRIS AG in Liqu (Filed by)
| Form SC 13G/A | |
01/22/2024
6:53 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/28/2023
3:22 PM | AC Immune (Subject)
Pfeifer Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
3:53 PM | AC Immune (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
12/19/2023
7:53 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/15/2023
4:27 PM | AC Immune (Filer)
| Form 424B5 | |
12/15/2023
3:31 PM | AC Immune (Subject)
Pfeifer Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/15/2023
6:27 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
3:18 PM | AC Immune (Subject)
Pfeifer Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
3:37 PM | AC Immune (Subject)
Pfeifer Andrea (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
6:13 AM | AC Immune (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
